盐酸西替利嗪 T0089

Product Introduction
Bioactivity


英文名: Cetirizine dihydrochloride

描述: Cetirizine dihydrochloride (UCB P071) 是羟嗪的羧化代谢物，是特异性口服有效的 H1 受体长效拮抗剂。它标记抗过敏特性，抑制过敏反应期间嗜酸性粒细胞趋化，可有效治疗过敏性鼻炎、确诊荨麻疹和花粉诱发的哮喘。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: H2O : 46.2 mg/mL (100 mM)
DMSO : 46.2 mg/mL (100 mM)


关键字: rhinitis | P-071 | Seasonal | histamine | UCB P-071 | P 071 | IL-8 | allergic | Cetirizine dihydrochloride | IL-1β | Inhibitor | GM-CSF | Histamine Receptor | inhibit | SAR | UCB P 071 | Cetirizine Dihydrochloride | Cetirizine

相关产品: Clemastine | FRG8701 | AVN-101 | Lidocaine | Pemirolast potassium | Ritanserin | Tesmilifene fumarate | H4R antagonist 2 | Enerisant HCl | Mebhydrolin napadisylate

相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Neuronal Signaling Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Orally Active Compound Library | NO PAINS Compound Library

盐酸西替利嗪 T0089信息由TargetMol中国为您提供，如您想了解更多关于盐酸西替利嗪 T0089报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途